Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sagopilone + Prednisone in mCRPC
NCT00350051Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of sagopilone in prostate cancer (PCa), sponsored by Bayer. Primary endpoint: Prostate-Specific Antigen Response. Started Aug 2006; status: completed.
02
Drugs
sagopilone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00350051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350051.